NasdaqGS - Nasdaq Real Time Price USD

Cytek Biosciences, Inc. (CTKB)

Compare
3.7450
-0.2450
(-6.14%)
As of 2:31:54 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
200,453
200,453
193,015
164,036
127,950
Cost of Revenue
89,347
89,347
83,589
63,062
48,806
Gross Profit
111,106
111,106
109,426
100,974
79,144
Operating Expense
131,629
131,629
137,271
102,778
69,987
Operating Income
-20,523
-20,523
-27,845
-1,804
9,157
Net Non Operating Interest Income Expense
10,360
10,360
4,342
2,046
-1,692
Other Income Expense
4,463
4,463
7,794
1,018
-1,527
Pretax Income
-5,700
-5,700
-15,709
1,260
5,938
Tax Provision
320
320
-3,561
-1,224
2,911
Net Income Common Stockholders
-6,020
-6,020
-12,148
2,576
--
Diluted NI Available to Com Stockholders
-6,020
-6,020
-12,148
2,576
--
Basic EPS
-0.05
--
-0.09
0.02
0.00
Diluted EPS
-0.05
--
-0.09
0.02
0.00
Basic Average Shares
130,611.3300
--
130,714.9060
134,510.8310
76,741.8580
Diluted Average Shares
130,611.3300
--
130,714.9060
138,562.1110
81,546.6970
Total Operating Income as Reported
-20,523
-20,523
-27,845
-1,804
9,157
Total Expenses
220,976
220,976
220,860
165,840
118,793
Net Income from Continuing & Discontinued Operation
-6,020
-6,020
-12,148
2,576
3,001
Normalized Income
-6,020
-6,020
-12,148
2,576
3,001
Interest Income
10,360
10,360
6,413
4,619
49
Interest Expense
--
--
2,071
2,573
1,741
Net Interest Income
10,360
10,360
4,342
2,046
-1,692
EBIT
-20,523
-20,523
-13,638
3,833
7,679
EBITDA
-10,033
-10,033
-4,408
9,492
8,921
Reconciled Cost of Revenue
89,347
89,347
83,589
63,062
48,806
Reconciled Depreciation
10,490
10,490
9,230
5,659
1,242
Net Income from Continuing Operation Net Minority Interest
-6,020
-6,020
-12,148
2,576
3,001
Normalized EBITDA
-10,033
-10,033
-4,408
9,492
8,921
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 7/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QTRX Quanterix Corporation
6.19
-7.89%
 
SGHT Sight Sciences, Inc.
2.2450
-0.22%
 
LAB Standard BioTools Inc.
1.0700
-9.32%
 
AXDX Accelerate Diagnostics, Inc.
0.7100
+1.43%
 
RPID Rapid Micro Biosystems, Inc.
2.4250
-12.34%
 
IRIX IRIDEX Corporation
0.9600
-6.80%
 
TMCI Treace Medical Concepts, Inc.
7.85
-5.65%
 
SHL1.F Siemens Healthineers AG
23.80
-2.46%
 
ALIKO.PA Ikonisys S.A.
1.5000
+4.17%
 
1RC.SG Creo Medical Group PLC
0.1650
0.00%